Roche (RHHBY) expects an increase in Group sales in the mid single digit range. Core earnings per share are targeted to develop in the high single digit range. Roche expects to further increase its dividend in Swiss francs.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RHHBY:
- Roche receives CE Mark for Elecsys pTau181
- Roche pauses shipments of Elevidys outside the U.S., Bloomberg says
- Roche announces European Commission approved Itovebi
- AstraZeneca (AZN) Commits to $50B U.S. Investment as Tariff Threat Looms
- Roche announces ALIENTO trial meets, ARNASA study misses primary endpoint
